What causes gestational diabetes?

Gestational Diabetes During and After Pregnancy

Volumn , Issue , 2010, Pages 113-123

  Buchanan, Thomas A ^a   Xiang, Anny H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889972433     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84882-120-0_8     Document Type: Chapter

References (62)

1. Metzger BE, Lowe LP, Dyer A.R., et al HAPO, Study Cooperative Research Group: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358: 1991-2002.
2. Beck P, Daughaday WH Human placental lactogen: Studies of its acute metabolic effects and disposition in normal man. J Clin Invest. 1967; 46: 103-109.
3. Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab. 2000; 13: 343-356.
4. Barbour LA, Shao J, Qiao L., et al Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol. 2002; 186: 512-517.
5. Kirwan JP, Haugel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002; 51: 2207-2213.
6. Barbour LA, McCurdy CE, Hernandez T.L., Kirwan JP, Catalano PM, Friedman JE Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diab Care. 2007; 30(SUPPL. 2): S112-S119.
7. Bergman RN. Toward a physiological understanding of glucose tolerance: minimal model approach. Diabetes. 1989; 38: 1512-1528.
8. Homko C, Sivan E, Chen X., Reece EA, Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab. 2001; 86: 568-573.
9. Buchanan TA, Xiang AH, Kjos S.L., Watanabe RM What is gestational diabetes? Diab Care. 2007; 30(SUPPL. 2): S105-S111.
10. Catalano PM, Huston L, Amini S.B., Kalhan SC Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am J Obstet Gynecol. 1999; 180: 903-916.
11. Catalano PM, Tzybir ED, Wolfe R.R., et al Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993; 264: E60-E67.
12. Petersen JS, Dyrberg T, Damm P., Kuhl C, Molsted-Pedersen L, Buschard K. GAD65 autoan-tibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy. Diabetologia. 1996; 39: 1329-1333.
13. Weng J, Ekelund M, Lehto M., et al Screening for MODY mutations, GAD antibodies, and type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus. Diab Care. 2002; 25: 68-71.
14. Mauricio D, Corcoy RM, Codina M, et al Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes shortly after pregnancy. Diab Nutr Metab. 1992; 5: 237-241.
15. Xiang AH, Peters RK, Trigo E, Kjos S.L., Lee WP, Buchanan TA Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes. 1999; 48: 848-854.
16. Catalano PM, Tyzbir ED, Sims EAH. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diab Care. 1990; 13: 478-482.
17. Jarvela IY, Juutinen J, Koskela P., et al Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age. Diab Care. 2006; 29: 612.
18. Lobner K, Knopff A, Baumgarten A., et al Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes. 2006; 55: 792-797.
19. Kousta E, Ellard S, Allen L.I., et al Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet Med. 2001; 18: 683-684.
20. Ellard S, Beards F, Allen L.I., et al A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia. 2000; 43: 250-253.
21. Saker PJ, Hattersley AT, Barrow B, et al High prevalence of a missense mutation of the glu-cokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia. 1996; 39: 1325-1328.
22. Chen Y, Liao WX, Roy A.C., Loganath A., Ng SC Mitochondrial gene mutations in gestational diabetes mellitus. Diab Res Clin Pract. 2000; 48: 29-35.
23. Catalano PM, Tyzbir ED, Roman N.M., Amini SB, Sims EA Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991; 165: 1667-1672.
24. Ward WK, Johnston CLW, Beard JC, Benedetti T.J., Halter JB, Porte D. Insulin resistance and impaired insulin secretion in subjects with a history of gestational diabetes mellitus. Diabetes. 1985; 34: 861-869.
25. Ward WK, Johnston CLW, Beard JC, Benedetti T.J., Porte D Jr. Abnormalities of islet B cell function, insulin action and fat distribution in women with a history of gestational diabetes: relation to obesity. J Clin Endocrinol Metab. 1985; 61: 1039-1045.
26. Catalano PM, Bernstein IM, Wolfe R.R., Srikanta S., Tyzbir E, Sims EAH. Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am J Obstet Gynecol. 1986; 155: 1255-1263.
27. Ryan EA, Imes S, Liu D., et al Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes. 1995; 44: 506-512.
28. Kautzky-Willer A., Prager R, Waldhausl W., et al Pronounced insulin resistance and inadequate betacell secretion characterize lean gestational diabetes during and after pregnancy. Diab Care. 1997; 20: 1717-1723.
29. Damm P, Vestergaard H, Kuhl C., Pedersen O. Impaired insulin-stimulated nonoxidative glucose metabolism in glucose-tolerant women with previous gestational diabetes. Am J Obstet Gynecol. 1996; 174: 722-729.
30. Osei K, Gaillard TR, Schuster DP History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African-American women with a parental history of type 2 diabetes. Diab Care. 1998; 21: 1250-1257.
31. Kautzky-Willer A., Pacini G, Tura A., et al Increased plasma leptin in gestational diabetes. Diabetologia. 2001; 44: 164-172.
32. Winkler G, Cseh K, Baranyi E., et al Tumor necrosis factor system and insulin resistance in gestational diabetes. Diab Res Clin Pract. 2002; 56: 93-99.
33. Retnakaran R, Hanley AJ, Raif N, Connelly P.W., Sermer M., Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab. 2003; 88: 3507-3512.
34. Retnakaran R, Hanley AJ, Raif N, Connelly P.W., Sermer M., Zinman B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diab Care. 2004; 27: 799-800.
35. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S., Song T, Luthy DA Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab. 2004; 89: 2306-2311.
36. Tiikkainen M, Tamminen M, Hakkinen A.M., et al Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res. 2002; 10: 859-867.
37. Kautzky-Willer A., Krssak M, Winzer C., et al Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes. 2003; 52(2): 244-251.
38. Catalano PM, Nizielski SE, Shao J, Preston L., Qiao L, Friedman JE Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol. 2002; 282: E522-E533.
39. Shao J, Yamashita H, Qiao L., Draznin B, Friedman JE Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. Diabetes. 2002; 51: 19-29.
40. Shao J, Catalano PM, Yamashita H, et al Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 over expression in skeletal muscle from obese women with gestational diabetes (GDM): evidence for increased serine/threonine phosphory-lation in pregnancy and GDM. Diabetes. 2000; 49: 603-610.
41. Friedman JE, Ishizuka T, Shao J., et al Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes. 1999; 48: 1807-1814.
42. Garvey WT, Maianu L, Zhu J.H., et al Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Diabetes. 1993; 42: 1773-1785.
43. Peters RK, Kjos SL, Xiang A, Buchanan TA Long-term diabetogenic effect of a single pregnancy in women with prior gestational diabetes mellitus. Lancet. 1996; 347: 227-230.
44. Xiang AH, Peters RK, Kjos S.L., et al Effect of pioglitazone on pancreatic β-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes. 2006; 55: 517-522.
45. Xiang AH, Peters RK, Kjos S.L., et al Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and β-cell function. J Clin Endocrinol Metab. 2004; 89: 2846-2851.
46. Buchanan TA, Xiang AH, Peters R.K., et al Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes. 2002; 51: 2796-2803.
47. Cnop M, Welsh N, Jonas N.C., Jorns A., Lenzen S, Eizirik DL Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes. 2005; 54(SUPPL. 2): S97-S107.
48. Scheuner D, Kaufman RJ The unfolded protein response: a pathway that links insulin demand with beta cell failure and diabetes. Endo Rev. 2008; 29: 317-333.
49. Eizirik DL, Cardoza AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endo Rev. 2008; 29: 42-61.
50. Janson J, Soeller WC, Roche P.C., et al Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Nat Acad Sci. 1996; 93: 7283-7288.
51. Verchere CB, D'Alessio DA, Palmiter RD, et al Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Nat Acad Sci. 1996; 93: 3492-3496.
52. Fridlyand LE, Philipson LH Reactive species, cellular repair, and risk factors in the onset of type 2 diabetes mellitus: review and hypothesis. Curr. Diabetes Rev. 2006; 2: 241-259.
53. Kim C, Newton KM, Knopp RH Gestational diabetes and the incidence of type 2 diabetes. Diab Care. 2002; 25: 1862-1868.
54. Kjos SL, Buchanan TA, Greenspoon J.S., Montoro M., Bernstein GS, Mestman JH Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum. Am J Obstet Gynecol. 1990; 163: 93-98.
55. Kousta E, Lawrence NJ, Penny A, et al Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diab Care. 1998; 22: 933-937.
56. Pearson ER, Starkey BJ, Powell R.J., Gribble FM, Clark PM, Hattersley AT Genetic causes of hyperglycaemia and response to treatment in diabetes. Lancet. 2003; 362: 1275-1281.
57. Spyer G, Hattersley AT, Sykes J.E., Sturley RH, MacLeod KM Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am J Obstet Gynecol. 2001; 185: 240-241.
58. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403.
59. Ratner RE, Christophi CA, Metzger B.E., et al Diabetes Prevention Program Research Group: Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle intervention. J Clin Endocrinol Metab. 2008; 93: 4774-4779.
60. Xiang AH, Peters RK, Kjos S.L., et al Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function. J Clin Endocrinol Metab. 2004; 89: 2846-2851.
61. Xiang AH, Wang C, Peters R.K., Trigo E., Kjos SL, Buchanan TA Coordinate changes in plasma glucose and pancreatic beta cell function in Latino women at high risk for type 2 diabetes. Diabetes. 2006; 55: 1074-1079.
62. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogen-esis and prevention of type 2 diabetes. J Clin Endocrinol Metab. 2001; 86: 989-993.